A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.

por Rajkumar, T., Gullick, W. J.
Publicado 1994

Epidermal Growth Factor Methods and Protocols

por Chan, S K, Gullick, W J
Publicado 2007

eph, the largest known family of putative growth factor receptors.

por Tuzi, N. L., Gullick, W. J.
Publicado 1994

Proteomic identification of secreted proteins as surrogate markers for signal transduction inhibitor activity

por McClelland, C M, Gullick, W J
Publicado 2007

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.

por Walker, R. A., Gullick, W. J., Varley, J. M.
Publicado 1989

Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway

por Clarke, K, Smith, K, Gullick, W J, Harris, A L
Publicado 2001

Pattern of expression of c-erbB-2 oncoprotein in human fetuses.

por Quirke, P., Pickles, A., Tuzi, N. L., Mohamdee, O., Gullick, W. J.
Publicado 1989

Expression of growth factor receptors in human brain tumours.

por Tuzi, N. L., Venter, D. J., Kumar, S., Staddon, S. L., Lemoine, N. R., Gullick, W. J.
Publicado 1991

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.

por Gullick, W. J., Love, S. B., Wright, C., Barnes, D. M., Gusterson, B., Harris, A. L., Altman, D. G.
Publicado 1991

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.

por Lemoine, N. R., Jain, S., Silvestre, F., Lopes, C., Hughes, C. M., McLelland, E., Gullick, W. J., Filipe, M. I.
Publicado 1991

Evaluation of epidermal growth factor receptors in bladder tumours.

por Berger, M. S., Greenfield, C., Gullick, W. J., Haley, J., Downward, J., Neal, D. E., Harris, A. L., Waterfield, M. D.
Publicado 1987

c-erbB-2 expression in benign and malignant breast disease.

por Gusterson, B. A., Machin, L. G., Gullick, W. J., Gibbs, N. M., Powles, T. J., Elliott, C., Ashley, S., Monaghan, P., Harrison, S.
Publicado 1988

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.

por Qi, C. F., Liscia, D. S., Normanno, N., Merlo, G., Johnson, G. R., Gullick, W. J., Ciardiello, F., Saeki, T., Brandt, R., Kim, N.
Publicado 1994

Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model

por Harrington, K J, Syrigos, K N, Uster, P S, Zetter, A, Lewanski, C R, Gullick, W J, Vile, R G, Stewart, J S W
Publicado 2004

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.

por Lovekin, C., Ellis, I. O., Locker, A., Robertson, J. F., Bell, J., Nicholson, R., Gullick, W. J., Elston, C. W., Blamey, R. W.
Publicado 1991

c-erbB-4 protein expression in human breast cancer

por Kew, T Y, Bell, J A, Pinder, S E, Denley, H, Srinivasan, R, Gullick, W J, Nicholson, R I, Blamey, R W, Ellis, I O
Publicado 2000

Expression of the ERBB3 gene product in breast cancer.

por Lemoine, N. R., Barnes, D. M., Hollywood, D. P., Hughes, C. M., Smith, P., Dublin, E., Prigent, S. A., Gullick, W. J., Hurst, H. C.
Publicado 1992

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

por Travis, A., Pinder, S. E., Robertson, J. F., Bell, J. A., Wencyk, P., Gullick, W. J., Nicholson, R. I., Poller, D. N., Blamey, R. W., Elston, C. W., Ellis, I. O.
Publicado 1996